CAV1 and pulmonary fibrosis: Lastly, exogenous Cav‐1 peptide injection effectively upregulated Cav‐1 levels, therapeutically influenced myocardial remodelling, BLM‐induced pulmonary fibrosis and LPS‐induced inflammation.33, 34